Back to top

QNCX Initiated by Oppenheimer -- Rating Set to Outperform with $82 Target

QNCX Initiated by Oppenheimer -- Rating Set to Outperform with $82 Target

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quince Therapeutics, Inc. (QNCX)